TIMING OF LEVODOPA THERAPY: EVIDENCE FROM MPTP-TREATED PRIMATES
- 14 March 1987
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 329 (8533) , 625
- https://doi.org/10.1016/s0140-6736(87)90260-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- WHEN SHOULD LEVODOPA BE STARTED?The Lancet, 1986
- Saccade responses to dopamine in human MPTP‐induced parkinsonismAnnals of Neurology, 1986
- Long‐term follow‐up of early dopa treatment in Parkinson's diseaseAnnals of Neurology, 1986
- RATIONALE FOR EARLY USE OF LEVODOPA IN PARKINSONISMThe Lancet, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Chronic low‐dose levodopa therapy in Parkinson's diseaseNeurology, 1984
- Evidence to support early levodopa therapy in Parkinson diseaseNeurology, 1981
- Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapyNeurology, 1979
- ParkinsonismNeurology, 1967